6MPG image
Deposition Date 2018-10-06
Release Date 2019-07-24
Last Version Date 2024-11-20
Entry Detail
PDB ID:
6MPG
Keywords:
Title:
Cryo-EM structure at 3.2 A resolution of HIV-1 fusion peptide-directed antibody, A12V163-b.01, elicited by vaccination of Rhesus macaques, in complex with stabilized HIV-1 Env BG505 DS-SOSIP, which was also bound to antibodies VRC03 and PGT122
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.20 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:A12V163-b.01 Light Chain
Chain IDs:A (auth: B), K (auth: 4), X (auth: Y)
Chain Length:113
Number of Molecules:3
Biological Source:Macaca mulatta
Polymer Type:polypeptide(L)
Molecule:Envelope glycoprotein gp41
Gene (Uniprot):env
Chain IDs:B (auth: U), P (auth: A), R (auth: D)
Chain Length:153
Number of Molecules:3
Biological Source:Human immunodeficiency virus 1
Polymer Type:polypeptide(L)
Molecule:Envelope glycoprotein gp120
Gene (Uniprot):env
Chain IDs:C (auth: V), I (auth: 2), Q (auth: C)
Chain Length:473
Number of Molecules:3
Biological Source:Human immunodeficiency virus 1
Polymer Type:polypeptide(L)
Molecule:A12V163-b.01 Heavy Chain
Chain IDs:D (auth: W), J (auth: 3), W (auth: X)
Chain Length:117
Number of Molecules:3
Biological Source:Macaca mulatta
Polymer Type:polypeptide(L)
Molecule:PGT122 Heavy chain
Chain IDs:E (auth: m), L (auth: 5), S (auth: M)
Chain Length:132
Number of Molecules:3
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:PGT122 Light chain
Chain IDs:F (auth: n), M (auth: 6), T (auth: N)
Chain Length:107
Number of Molecules:3
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:VRC03 heavy chain
Chain IDs:G (auth: q), O (auth: 8), U (auth: Q)
Chain Length:227
Number of Molecules:3
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:VRC03 Light chain
Chain IDs:H (auth: r), N (auth: 7), V (auth: R)
Chain Length:102
Number of Molecules:3
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation

Abstact

The vaccine-mediated elicitation of antibodies (Abs) capable of neutralizing diverse HIV-1 strains has been a long-standing goal. To understand how broadly neutralizing antibodies (bNAbs) can be elicited, we identified, characterized, and tracked five neutralizing Ab lineages targeting the HIV-1-fusion peptide (FP) in vaccinated macaques over time. Genetic and structural analyses revealed two of these lineages to belong to a reproducible class capable of neutralizing up to 59% of 208 diverse viral strains. B cell analysis indicated each of the five lineages to have been initiated and expanded by FP-carrier priming, with envelope (Env)-trimer boosts inducing cross-reactive neutralization. These Abs had binding-energy hotspots focused on FP, whereas several FP-directed Abs induced by immunization with Env trimer-only were less FP-focused and less broadly neutralizing. Priming with a conserved subregion, such as FP, can thus induce Abs with binding-energy hotspots coincident with the target subregion and capable of broad neutralization.

Legend

Protein

Chemical

Disease

Primary Citation of related structures